PubMed-compiled information sheet
This sheet was compiled from PubMed (NIH) abstracts using AI assistance. Every factual claim is cited to a real PubMed article (see the source list). It has not yet been human-reviewed — confirm with a healthcare provider before use.
Compiled from 30 PubMed articles · model: gemma4:31b
Summary
Background
Traditional uses
Active compounds
Mechanism of action
Clinical evidence
Intake of Kombu improved molecular species profiles of serum lipids in subjects with abnormally high serum triglyceride levels [PMID:32350180]
Consumption of cookies containing boiled kombu powder significantly decreased body fat percentage and systolic blood pressure in healthy Japanese adults [PMID:40390848]
Laminaria japonica polysaccharides exhibit anti-inflammatory, antioxidant, and antidiabetic effects [PMID:35893900, 34530347]
L. japonica fucoidan inhibited the binding of HuNoV GII.4 and GII.17 to saliva and improved survival rates in MNoV-infected mice [PMID:32906822]
Specific polysaccharide fractions (S-C fraction) inhibited cancer cell viability, migration, and invasion in vitro and reduced lung metastasis in mice [PMID:40517857]
Safety & adverse effects
Evidence summary
PubMed sources
- 1.PMID: 22054948 (2011) — Laminaria japonica as a food for the prevention of obesity and diabetes. · Advances in food and nutrition research
- 2.PMID: 18689954 (2008) — Suppression of thyroid function during ingestion of seaweed "Kombu" (Laminaria japonoca) in normal Japanese adults. · Endocrine journal
- 3.PMID: 15866005 (2005) — Transforming kelp into a marine bioreactor. · Trends in biotechnology
- 4.PMID: 39728140 (2024) — The Beneficial Roles of Seaweed in Atopic Dermatitis. · Marine drugs
- 5.PMID: 36869543 (2023) — A review of volatile compounds in edible macroalgae. · Food research international (Ottawa, Ont.)